KDM5B is overexpressed in gastric tumors, being related to tumor proliferation, migration, and invasion, with reduced immune cell infiltration within the tumor, and it is associated with poor prognostic outcomes, functioning as a tumor promoter. Here, KDM5B is linked to gastric neoplasm.